Cargando…
New Therapeutic Targets for Mood Disorders
Existing pharmacological treatments for bipolar disorder (BPD) and major depressive disorder (MDD) are often insufficient for many patients. Here we describe a number of targets/compounds that clinical and preclinical studies suggest could result in putative novel treatments for mood disorders. Thes...
Autores principales: | Machado-Vieira, Rodrigo, Salvadore, Giacomo, DiazGranados, Nancy, Ibrahim, Lobna, Latov, David, Wheeler-Castillo, Cristina, Baumann, Jacqueline, Henter, Ioline D., Zarate, Carlos A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
TheScientificWorldJOURNAL
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035047/ https://www.ncbi.nlm.nih.gov/pubmed/20419280 http://dx.doi.org/10.1100/tsw.2010.65 |
Ejemplares similares
-
The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments
por: Machado-Vieira, Rodrigo, et al.
Publicado: (2010) -
Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder
por: Machado-Vieira, Rodrigo, et al.
Publicado: (2023) -
PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects
por: Richards, Erica M., et al.
Publicado: (2018) -
Ketamine treatment for depression: a review
por: Yavi, Mani, et al.
Publicado: (2022) -
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
por: Kadriu, Bashkim, et al.
Publicado: (2018)